Gainers

• Apimeds Pharmaceuticals (AMEX:APUS) shares moved upwards by 52.5% to $7.0 during Tuesday's regular session. The company's market cap stands at $6.9 million.
• Option Care Health (NASDAQ:OPCH) stock increased by 33.07% to $31.1. The market value of their outstanding shares is at $3.5 billion.
• Jaguar Health (NASDAQ:JAGX) stock increased by 23.04% to $5.82. The market value of their outstanding shares is at $2.4 million.
• FF EAI Robotics Ecosystem (NASDAQ:FFR) shares increased by 18.58% to $1.34. The market value of their outstanding shares is at $23.8 million.
• Trinity Biotech (NASDAQ:TRIB) shares rose 17.85% to $6.8. The company's market cap stands at $4.6 million.
• Conexeu Sciences (NASDAQ:CNXU) shares rose 16.18% to $3.62. The company's market cap stands at $88.0 million.

Losers

• ArriVent BioPharma (NASDAQ:AVBP) stock decreased by 45.2% to $15.59 during Tuesday's regular session. The market value of their outstanding shares is at $1.4 billion.
• Flyte Aviation (AMEX:VJET) shares fell 37.66% to $1.01. The market value of their outstanding shares is at $3.4 million.
• Kairos Pharma (AMEX:KAPA) stock declined by 24.52% to $1.17. The market value of their outstanding shares is at $5.2 million.
• YD Bio (NASDAQ:YDES) shares declined by 23.99% to $5.41. The company's market cap stands at $503.6 million.
• China SXT Pharmaceuticals (NASDAQ:SXTC) stock declined by 21.16% to $1.64. The company's market cap stands at $1.1 million.
• PDS Biotechnology (NASDAQ:PDSB) stock decreased by 18.52% to $0.98. The market value of their outstanding shares is at $86.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.